Comparative medicine

Comparative medicine is a distinct discipline of experimental medicine that uses animal models of human and animal disease in translational and biomedical research.[1]: 2 [2] In other words, it relates and leverages biological similarities and differences among species to better understand the mechanism of human and animal disease. It has also been defined as a study of similarities and differences between human and veterinary medicine including the critical role veterinarians, animal resource centers, and Institutional Animal Care and Use Committees play in facilitating and ensuring humane and reproducible lab animal care and use.[3] The discipline has been instrumental in many of humanity's most important medical advances.

History

The ancient world
Hippocrates, Aphorismi, manuscript. Wellcome L0002463

The first documented mention of comparative pathology comes from Hippocrates (460 - 370 BCE) in Airs, Waters, Places where he describes relevant case histories for horse herds and human populations. He insists that diagnosis be based on experience, observation, and logic.[4] Aristotle (384 - 322 BCE) hypothesized about interspecies transmission of disease.[1]: 4  The anatomy and physiology schools opened in Alexandria by Erasistratus (404 - 320 BCE) and Herophilus (330 - 255 BCE) were directly inspired by Aristotle's work. Although most of the documents were destroyed when the Library of Alexandria burned.[5]

In his Disciplinarum Libri IX, Marcus Terentius Varro (c. 100 BCE) made early indications of the germ theory of disease with his conception that tiny invisible animals carried with the air caused disease by entering through the nose and mouth.[6] He also warned people against establishing homes near swamplands.[7] Aulus Cornelius Celsus (25 BCE - 50 CE) wrote of experimental physiology in De Medicini Libri Octo detailing numerous dissections and vivisections he performed and pointed out specific interventions as well, such as cupping to remove the poison of a dog's bite.[8][6]: 8 

By the time of Claudius Galen (129 - 200 CE), whose name lives on in the term Galenic formulation, human dissection was no longer acceptable and his vivisection studies of comparative anatomy relied mostly on the use of Barbary macaques.[9] This resulted in several persistent misunderstandings of human anatomy.[10] Another key early contributor to early comparative medicine through publication of his Digestorum Artis Mulomedicinae libri in 500 CE was Publius Flavius Vegetius Renatus. A work that continued to be published and used in medicine as late as the 16th century.[1]: 5 

Middle ages and early renaissance

The post-antique European world gave rise to a dominant monotheistic culture and with it a de facto ban on human dissection. As such, there was a slow down in comparative medicine's progress through the middle ages. This was to be codified in 1637 CE with René Descartes manuscript Discourse on the Method.[11]: 11  The Persian physician Muhammad ibn Zakariya al-Razi (865 - 925 CE) was the first to describe smallpox and measles and prescribe treatments, making his discoveries largely through animal dissection.[12]

Due to the far flung nature of their travels the Crusaders imported the Oriental rat flea carrying the bacterium Yersinia pestis and eventually initiating the Black Death.[13] The massive deleterious effect of the pandemic brought on serious consideration of inoculation and transmission chiefly through the work of Albertus Magnus (1206 - 1280 CE). In the book Liber de Animalibus he discussed human and animal plagues in addition to narrowing down the method of transmission to bites, contact with animals, or respiration of sick air from the diseased.[14]

Girolamo Fracastoro (1478 - 1553 CE) outlined a concept for rapidly multiplying minute bodies (germs) transmitting infection in De contagione et contagiosis morbis. The theory was widely praised but fell into disuse until Louis Pasteur and Robert Koch developed an empirical version.[15] The beginnings of microbiology, and thus serious use of comparative medicine, were finally enabled by Antonie Philips van Leeuwenhoek's refinement of the microscope and subsequent observation of animalcules.[16]

The early modern period
A text-book of comparative physiology (microform) - for students and practitioners of comparative (veterinary) medicine (1890) (20011433214)

The first real basis for the structured and regular exchange of knowledge of science and medicine in the western world was established with the 1660 founding of the Royal Society in London. Robert Doyle (1627 - 1691) published key experiments in their classical journal Philosophical Transactions among them interspecies blood transfusion, including from sheep into men.[17]

The 18th century brought new plagues[13] and faster communications to Europe creating a fruitful environment for a comparative approach to transfer and contagion. Along with the technology of transference as an experimental in vivo approach to medicine.[1]: 7  At this stage it was already established in China that it was possible to use pox crusts as an effective treatment for smallpox infections.[18] Emanuel Timone (1665 - 1741) was the first westerner to publish anything on inoculation, which he called grafting, although it's unclear if he developed it de novo (as new) or inferred it from previous work.[19]

At this point animal medicine was generally absent from Europe. Bernado Ramazzini (1633 - 1714) and Giovanni Maria Lancisi (1654 - 1720) were the first to draw attention to the danger the general population faced from animal plagues.[20] This and other work paved the way for Mortimer Cromwell, a secretary of the Royal Society, to raise plagues as a national health issue enabling a general policy of quarantine, isolation, fumigation, and slaughter.[21] Erasmus Darwin was also impacted by the tragedy of the plagues and it resulted in the publication of his Zoonomia where he discusses infectious disease of both humans and animals.

In 1802 French physiologist François Magendie (1783 - 1855) became the first person to prove interspecies transmission of disease by inoculating a dog from rabies using human spittle.[22] He also experimented with the injection of putrid fish into animals and was an advocate for experimentation in a time before anesthetics were developed.[23]

With their usefulness to human health and respectable scientific standing established there were veterinary colleges founded in France, Austria, Sweden, Denmark, Netherlands, and Germany throughout the 18th century. It was Claude Bourgelat, the founder of the first veterinary college in Lyon France in 1761, who, prior to the existence of the veterinary profession, coined the term “comparative pathobiology”.[3] When the Royal Veterinary College was established in London in 1790 many students from France moved to England. Among them were John Hunter (1728 - 1793) an anatomist and surgeon that had an interest in comparative anatomy and animal physiology. His teaching on infectious disease was influential on subsequent generations.

Modern medicine

A most prominent student of Hunter's was Edward Jenner (1749 - 1823). He introduced animal models for rabies and showed that dogs could be inoculated with the spittle of infected animals. In a 1796 experiment, Jenner demonstrated inoculation from smallpox by exposure to and transmission of the milder cowpox. Jenner's work, a breakthrough in vaccinology and an important precursor to immunology in general, is generally credited as the very beginning of modern medicine.[24] The experiments of Jenner and others set the stage for certain inoculation programs to be introduced to the general public. The first of such programs was directed by Jean-Baptist Edouard Bousquet (1794 - 1872) laid out guidelines for advisability, inoculation, and re-inoculation.[25]

The first university chair of comparative medicine was established in 1862 resultant to the vision of Émile Littré a French politician and former student of medicine.[26]

Robert Koch (1843 - 1910) discovered the pathogens responsible for anthrax, tuberculosis, and cholera. He won a Nobel Prize in Physiology or Medicine in 1905[27] He used animal models to complement knowledge of human biology.[28]

In 1863 John Gamgee (1831 - 1894) organized the first conference of what would evolve into the World Veterinary Association.[29] Subsequent conferences, such as one on animal vaccination in 1880, led George Fleming to propose in The Lancet that a chair of comparative pathology be established in all medical schools.[30]

Rudolf Virchow (1821 - 1902) initiated modern pathology with his studies of dogs that lead to distinguishing between pyemia, sepsis, thrombosis, and embolisms. He made observations based on experiments in animals that led to specific medical interventions for humans, a hallmark of comparative medicine.[1]: 11 

Auguste Chauveau (1827 - 1917) experimented on sepsis, and chaired a commission that was responsible for anticipating that smallpox itself could be attenuated by passage through cattle.[31][32]

Louis Pasteur (1822 - 1895) inoculated several animal species against rabies and was able to cure a young boy of the disease. There was much controversy surrounding Pasteur's work after his death when his lab notebooks revealed questionable reporting techniques and the suppression of the work of others in his field such as Pierre Paul Émile Roux.[33]

Salomon Stricker (1834 - 1898) founded The Institute of Experimental Pathology in 1872, which in 2010 was renamed the Institute of Pathophysiology and Allergy Research to conform to modern nomenclature. From its inception the institute was devoted to laboratory experimentation involving animals.[34]

William H. Welch (1850 - 1934) was the founding president of the Rockefeller Institute of Medical Research in 1901. It was the first American equivalent to the Pasteur and Koch institutes in Europe. In addition to establishing an institute for animal pathology they began publishing the Journal of Experimental Medicine (JEM) which is still a respected journal today. They are dedicated to the study on intact organisms and prioritize human studies.[35]

Comparative medicine in the form of experimentation on rhesus monkeys was key to one of the crowning achievements of modern medical science: Jonas Salk's development of the polio vaccine. In fact the typing portion of the studies - crucial for determining what type of vaccine was needed - required some 17,000 monkeys for the research.[36] This lead Julius Youngner, one of the researchers on Salk's team to say, "The monkeys were the real heroes of this thing,"[37]

After polio and into the 21st century

HIV/AIDS research
Main article: HIV/AIDS research

Comparative medicine, particularly through the use of macaque and rhesus monkeys as animal models, has been absolutely essential to the development of treatment for HIV and AIDS. This is particularly so in the ongoing - and as yet unsuccessful - struggle to find a vaccine,[38] although there are severe limitations due to the uniqueness of Simian immunodeficiency virus (SIV) compared to the human virus and a better animal model is needed.[39]

One medicine
Main article: One Medicine

The concept of One Medicine is an idea from the 1970s and can be attributed to Calvin Schwabe (1927 – 2006) from his book Veterinary Medicine and Human Health. The idea takes the existing interdisciplinary nature of comparative medicine a step further and considers veterinary and human healthcare to be sufficiently overlapped as to be different aspects of the same thing.[40] These concepts are carried into the 21st century in works such as Zoobiquity[41][42] and in developments in research for heart transplants, management of psychiatric disorders, prosthetic limbs, cancer treatments and vaccine development.[43] Despite the potential of this emergent field it has thus far failed to realize its full potential due to the limited interaction of veterinary and medical sciences.[44]

Research concerns

The translational gap

Despite the usefulness of a comparative approach to medicine and the utility of animal models the literature is fraught with many examples of promising in vivo research failing to translate effectively from animals to humans.[45] This has raised concerns about reliability, predictive value, and the potential harm that inadequate measures can cause people.[46] Some researchers have noted that a distinction between exploratory and confirmatory approaches can improve translation.[47]

A few examples:

  • In 2004, an anti inflammatory drug called rofecoxib (also as Vioxx) was withdrawn after a reported 88,000-140,000 people suffered heart attacks.[48][49]
  • 150 potential treatments for stroke, considered successful following animal tests have gone on to fail in human clinical trials.[50]
  • In 2013, human trials of an HIV vaccine, based on experiments in monkeys, were halted when it was discovered that the vaccine did not work.[51]
  • In 2007, a drug for Parkinson's disease, CEP-1347, failed clinical trial in humans after being considered successful in animal tests.[52]
  • Many potential treatments for Alzheimer's disease have failed. The rate of attrition recently being announced as an 'astounding 99.6%'.[53] A recent study looked at 244 compounds in 413 clinical trials for Alzheimer's disease between 2002 and 2012. Of those only one was approved.[54]
  • A US study concluded that only one of eight drugs which enter clinical trials will be approved, with 80% of new drugs being abandoned by drugs companies.[55]

There is a current focus in the research community on using the proper context for interpreting animal models and developing better ones.[56]

Reproducibility

Reproducibility has been defined as the ability of a result to be replicated through independent experiments within the same or different laboratories. There are serious concerns about the repeatability of pre-clinical trials with published estimates of irreproducibility ranging from 51%[57] to 89%.[58] These concerns are part of the larger reproducibility crisis in science.[59][60]

Some of the reasons for the lack of reproducibility in many studies are:

  • Poor study design, errors in research, and potential fraud.[61]
  • An over-reliance on statistical significance coupled with small study sizes.[62]
  • At the 2nd International Symposium on Systematic Reviews in Laboratory Animal Science (2013) it was pointed out that publication bias and lack of sufficient power analysis is an issue.[63]
  • Research done across multiple labs at the same time, even as few as 2 to 4, shows a significantly better chance of being replicable.[64]

Ethics
Main article: Animal ethics

The theory of utilitarianism and the concept of greater good is most often used as a rationale for animal research in comparative medicine and elsewhere.[65] The basic idea is that the actions that produce the greatest good for the greatest number are moral actions,[66] meaning that new drugs and therapies along with the decreased suffering of humans and animals justifies the use of some animals in research. There are concerns that animal experimentation that has no translational benefit or reproducibility is likely unethical.[46]

There are philosophers that believe that animal testing violates an animal's dignity and is ethically wrong.[67] Until a better alternative is found though the majority of the scientific community continue to take the utilitarian approach.[68]

Main article: Animal testing regulations

Animal testing regulations are laws and/or guidelines that permit and control the use of animals for experimentation. They are of interest to comparative medicine given the overlap of the discipline and animal experimentation. The regulations vary around the world, but most governments aim to control the number of times animals are used; numbers used; and degree of pain.

See also

References
  1. Jensen-Jarolim, E. (2013). Comparative Medicine: Anatomy and Physiology. Springer Science & Business Media. ISBN 9783709115596. Retrieved 24 May 2018.
  2. Bradley, O. C. (November 1927). "What is Comparative Medicine?". Proceedings of the Royal Society of Medicine. 21 (1): 129–134. doi:10.1177/003591572702100129. PMC 2101790. PMID 19986145.
  3. Macy, J.; Horvath, T. L. (September 2017). "Comparative Medicine: An Inclusive Crossover Discipline". Yale Journal of Biology and Medicine. 90 (3): 493–498. PMC 5612191. PMID 28955187.
  4. Adams, F. (1849). The Genuine Works of Hippocrates, Volume 1. Oxford University: Sydenham Society. Retrieved 25 May 2018.
  5. Staden, H. V. (1989). Herophilus: The Art of Medicine in Early Alexandria: Edition, Translation and Essays. Cambridge University Press. pp. 37–38. ISBN 9780521236461. Retrieved 25 May 2018.
  6. Wilkenson, L. (1992). Animals and Disease: An Introduction to the History of Comparative Medicine. Cambridge University Press. ISBN 9780521375733. Retrieved 25 May 2018.
  7. Hempelmann, Ernst; Krafts, Kristine (October 2013). "Bad Air, Amulets and Mosquitoes: 2,000 Years of Changing Perspectives on Malaria". Malaria Journal. 12: 232. doi:10.1186/1475-2875-12-232. ISSN 1475-2875. PMC 3723432. PMID 23835014.
  8. Barrett, A. D. T.; Stanberry, L. R. (2009). Vaccines for Biodefense and Emerging and Neglected Diseases. Academic Press. p. 611. ISBN 9780080919027. Retrieved 25 May 2018.
  9. Lyons, A. S.; Petrucelli, J. (1978). Medicine: An Illustrated History. The University of California: Abradale Press/Abrams. ISBN 9780810980808. Retrieved 25 May 2018. medicine: an illustrated history.
  10. Aufderheide, A. C. (2003). The Scientifi Study of Mummies. Cambridge University Press. p. 454. ISBN 9780521818261. Retrieved 25 May 2018.
  11. Vaughan Monamy (23 February 2017). Animal Experimentation: A Guide to the Issues. Cambridge University Press. pp. 9–. ISBN 978-1-107-16202-0.
  12. Morgan, M. H. (2007). Lost History: The Enduring Legacy of Muslim Scientists, Thinkers, and Artists. National Geographic Books. ISBN 9781426202803. Retrieved 25 May 2018. a tribute to zakariya razi (865-925 AD), an iranian pioneer scholar.
  13. Haensch, S.; Bianucci, R.; Signoli, M.; Rajerison, M.; Shultz, M.; Kacki, S.; Vermunt, M.; Weston, D. A.; Hurst, D.; Achtman, M.; Carniel, E.; Bramanti, B. (7 October 2010). "Distinct Clones of Yersinia pestis Caused the Black Death". PLOS Pathogens. 6 (10): e1001134. doi:10.1371/journal.ppat.1001134. PMC 2951374. PMID 20949072.
  14. Magnus, A. Liber de animalibus Volume 15 of Beiträge zur Geschichte der Philosophie des Mittelalters Volume 1 of De animalibus libri XXVI, Albertus (Magnus.). Retrieved 25 May 2018.
  15. Rogers, K.; Young, G. "Girolamo Fracastoro". Encyclopedia Britannica. Retrieved 25 May 2018.
  16. Dobell, Clifford (1960) [1932]. Antony van Leeuwenhoek and His "Little Animals": being some account of the father of protozoology and bacteriology and his multifarious discoveries in these disciplines (Dover Publications ed.). New York: Harcourt, Brace and Company.
  17. Hunter, M. (2016). Boyle Studies: Aspects of the Life and Thought of Robert Boyle (1627-91). Routledge. p. 61. ISBN 9781317172871. Retrieved 25 May 2018.
  18. Temple, R. K. G. (2013). The Genius of China: 3,000 Years of Science, Discovery & Invention. Andre Deutsch. ISBN 9780233004006. Retrieved 25 May 2018.
  19. La Condamine, C.-M. de (September 2008). The history of inoculation. Retrieved 25 May 2018. {{cite book}}: |website= ignored (help)
  20. Klaassen, Z.; Chen, J.; Dixit, V.; Tubbs, R. S.; Soja, M. M.; Loukas, M. (October 2011). "Giovanni Maria Lancisi (1654-1720): anatomist and papal physician". Clinical Anatomy. 24 (7): 802–6. doi:10.1002/ca.21191. PMID 21739476. S2CID 205536323.
  21. Spinage, C. A. (2003). Cattle Plague: A History. Springer Cience & Business Media. p. 123. ISBN 9780306477898. Retrieved 25 May 2018.
  22. Stahnisch, F. (2012). Medicine, Life and Function: Experimental Strategies and Medical Modernity at the Intersection of Pathology and Physiology. Project Verlag. ISBN 9783897332577. Retrieved 29 May 2018.
  23. Linzay, A. (2013). The Global Guide to Animal Protection. University of Illinois. p. 272. ISBN 9780252094897. Retrieved 29 May 2018.
  24. Riedel, S. (January 2005). "Edward Jenner and the history of smallpox and vaccination". Baylor University Medical Center Poroceedings. 18 (1): 21–25. doi:10.1080/08998280.2005.11928028. PMC 1200696. PMID 16200144.
  25. Plotkin, S. A. (2011). History of Vaccine Development. Springer Science and Business Media. ISBN 9781441913395. Retrieved 29 May 2018.
  26. Vertes, A. A.; Queshi, N.; Caplan, A. I.; Babiss, L. E. (2015). Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies. Jon Wiley & Sons. p. 289. ISBN 9781118846216. Retrieved 24 May 2018.
  27. "The Nobel Prize in Physiology or Medicine 1905". Nobelprize.org. Retrieved 29 May 2018.
  28. Brock, T. D. (1988). Robert Koch: A Life in Medicine and Bacteriology. ASM Press. ISBN 9781555811433. Retrieved 29 May 2018.
  29. Hunter, P. (2016). Veterinary Medicine: A Guide to Historical Sources. Routledge. ISBN 9781351876049. Retrieved 29 May 2018.
  30. Fleming, G. (1871). Animal Plagues: Their History, Nature, and Prevention, Volume 1. Harvard University: Chapman and Hall. Retrieved 29 May 2018.
  31. Bazin, H. (2011). Vaccination: A History from Lady Montagu to Genetic Engineering. John Libbey Eurotext. p. 369. ISBN 9782742007752. Retrieved 29 May 2018.
  32. Swiderski, R. M. (2004). Anthrax: A History. McFarlan. p. 145. ISBN 9780786481965. Retrieved 29 May 2018.
  33. Geison, G. L. (2016). The Private Science of Louis Pasteur. Princeton University Press. ISBN 9780691633978. Retrieved 29 May 2018.
  34. Lasky, E. (1976). The Vienna Medical School of the 19th century. Johns Hopkins University Press. ISBN 9780801819087. Retrieved 29 May 2018.
  35. Ackerknecht, E. H.; Haushofer, L. (2016). A Short History of Medicine. JHU Press. ISBN 9781421419558. Retrieved 29 May 2018.
  36. Bookchin, D.; Shumacker, J. (2005). The Virus and the Vaccine: Contaminated Vaccine, Deadly Cancers, and Government Neglect. Macmillan. ISBN 9780312342722. Retrieved 29 May 2018.
  37. Spice, B. (April 2005). "Developing a medical milestone: the Salk polio vaccine". Pittsburgh Post Gazette. Archived from the original on 2010-03-11. Retrieved 29 May 2018.
  38. Hatziioannou, T.; Evans, D. T. (16 November 2012). "Animal models for HIV/AIDS research". Nature Reviews Microbiology. 10 (12): 852–867. doi:10.1038/nrmicro2911. PMC 4334372. PMID 23154262.
  39. Ambrose, Z.; et al. (August 2007). "HIV/AIDS: in search of an animal model". Trends in Biotechnology. 25 (8): 333–337. doi:10.1016/j.tibtech.2007.05.004. PMID 17574286.
  40. Schwabe, C. W. (1984). Veterinary Medicine and Human Health. Williams and Wilkens. ISBN 9780683075946. Retrieved 29 May 2018.
  41. Greek, R. (1 October 2012). "Zoobiquity: What Animals Can Teach Us About Health and the Science of Healing". Animals. 2 (4): 559–563. doi:10.3390/ani2040559. PMC 4494279.
  42. Natterson-Horowitz, B.; Bowers, K. (2013). Zoobiquity: The Astonishing Connection Between Human and Animal Health. Vintage Books, a division of Random House, Incorporated. ISBN 9780307477439. Retrieved 29 May 2018.
  43. Stroud, C.; Dimetriev, I.; Kashentseva, E.; et al. (August 2016). "A One Health overview, facilitating advances in comparative medicine and translational research". Clinical and Translational Medicine. 2 (26): 26. doi:10.1186/s40169-016-0107-4. PMC 4996801. PMID 27558513.
  44. Michell, A. (October 2000). "Only one medicine: the future of comparative medicine and clinical research". Research in Veterinary Science. 61 (2): 101–106. doi:10.1053/rvsc.2000.0401. PMID 11020358.
  45. Harris, R. "Drugs That Work In Mice Often Fail When Tried In People". npr.org. National Public Radio. Retrieved 30 May 2018.
  46. Akhtar A (2015). "The flaws and human harms of animal experimentation". Camb Q Healthc Ethics. 24 (4): 407–19. doi:10.1017/S0963180115000079. PMC 4594046. PMID 26364776.
  47. Kimmelman J, Mogil JS, Dirnagl U (2014). "Distinguishing between exploratory and confirmatory preclinical research will improve translation". PLOS Biol. 12 (5): e1001863. doi:10.1371/journal.pbio.1001863. PMC 4028181. PMID 24844265.
  48. Pippin, J. J. "The Need for Revision of Pre-Market Testing: The Failure of Animal Tests of COX-2 Inhibitors" (PDF). Federal Drug Administration. Archived from the original (PDF) on 21 September 2015. Retrieved 30 May 2018.
  49. Bhattacharya, S. "Up to 140,000 heart attacks linked to Vioxx". newscientist.com. Retrieved 30 May 2018.
  50. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010). "Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research". J Pharmacol Pharmacother. 1 (2): 94–9. doi:10.4103/0976-500X.72351. PMC 3043335. PMID 21350617.
  51. Steenhuysen, J. (25 April 2013). "Experimental HIV Vaccine Fails; Study Halted". Huffington Post. Retrieved 30 May 2018.
  52. Parkinson Study Group PRECEPT Investigators (2007). "Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease". Neurology. 69 (15): 1480–90. doi:10.1212/01.wnl.0000277648.63931.c0. PMID 17881719. S2CID 24633019.
  53. Carroll, J. (3 July 2014). "Alzheimer's R&D suffers as trial failure rate hits an 'astounding' 99.6%". fiercebiotech.com. Retrieved 30 May 2018.
  54. Cummings, J. L.; Morstorf, T.; Zhong, K. (3 July 2014). "Alzheimer's disease drug-development pipeline: few candidates, frequent failures". Alzheimer's Research & Therapy. 6 (37): 37. doi:10.1186/alzrt269. PMC 4095696. PMID 25024750.
  55. Seiffert, D. (21 November 2014). "Tufts study: it takes eight drugs in clinical trials to get one approval". Boston Business Journal. Retrieved 30 May 2018.
  56. McGonigle, P.; Ruggeri, B. (1 January 2014). "Animal models of human disease: Challenges in enabling translation". Biochemical Pharmacology. 87 (1): 162–171. doi:10.1016/j.bcp.2013.08.006. PMID 23954708.
  57. Lee C (2012). "Open peer review by a selected-papers network". Front Comput Neurosci. 6: 1. doi:10.3389/fncom.2012.00001. PMC 3264905. PMID 22291635.
  58. Begley CG, Ellis LM (2012). "Drug development: Raise standards for preclinical cancer research". Nature. 483 (7391): 531–3. Bibcode:2012Natur.483..531B. doi:10.1038/483531a. PMID 22460880. S2CID 4326966.
  59. Begley, C . P.; Loannidis, J. P. A. (2016). "Reproducibility in Science: Improving the Standard for Basic and Preclinical Research". Circulation Research. 116 (1): 116–126. doi:10.1161/CIRCRESAHA.114.303819. PMID 25552691.
  60. "Unreliable research: trouble at the lab". The Economist. 2013-10-18. Retrieved 30 May 2018.
  61. Pritt SL, Hammer RE (2017). "The Interplay of Ethics, Animal Welfare, and IACUC Oversight on the Reproducibility of Animal Studies". Comp Med. 67 (2): 101–105. PMC 5402729. PMID 28381309.
  62. Ioannidis JP (2005). "Why most published research findings are false". PLOS Med. 2 (8): e124. doi:10.1371/journal.pmed.0020124. PMC 1182327. PMID 16060722.
  63. Whaley, P. (2013-03-12). "Publication bias and underpowered studies as systemic weaknesses in animal research". policyfromscience.com. Retrieved 30 May 2018.
  64. Voelkl, B.; Vogt, L.; Sena, E. S.; Würbel, H. (22 February 2018). "Reproducibility of preclinical animal research improves with heterogeneity of study samples". PLOS Biology. 16 (2): e2003693. doi:10.1371/journal.pbio.2003693. PMC 5823461. PMID 29470495.
  65. Jerrold Tannenbaum (1995). Veterinary Ethics: Animal Welfare, Client Relations, Competition, and Collegiality. Mosby. ISBN 978-0-8151-8840-7.
  66. Bernard E. Rollin (27 March 2006). Science and Ethics. Cambridge University Press. ISBN 978-1-139-45504-6.
  67. Humphreys, R. (2016). "Dignity and Its Violation Examined within the Context of Animal Ethics". Ethics and the Environment. 21 (2): 143–162. doi:10.2979/ethicsenviro.21.2.06. S2CID 151492808. Retrieved 30 May 2018.
  68. Khoo SY (2018). "Justifiability and Animal Research in Health: Can Democratisation Help Resolve Difficulties?". Animals. 8 (2): 28. doi:10.3390/ani8020028. PMC 5836036. PMID 29443894.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.